Drugs / Alpha-Linolenic Acid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07392723 | Jan 2025 → Apr 2027 expected | Alzheimer disease, senile degeneration of brain | Michal Schnaider Beeri, Ph.D. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Alpha-Linolenic Acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07392723 ↗ |
| Route | Oral | “5 mL prefilled oral syringes” NCT07392723 ↗ |